Philip D Gregory

USPTO Granted Patents = 62 (Patent Applications = 12)

CIPO Patents = 19 (Patent Applications = 4)

EPO Patents = 23 (Patent Applications = 27)

Average Co-Inventor Count = 4.2

ph-index = 19

Forward Citations = 1,699(Granted Patents)

Inventors with similar research interests:

Location History:

El Cerrito, CA (US) (2005 - 2007)
Orinda, CA (2017)
Cambridge, MA (US) (2017)
Orinda, CA (US) (2008 - 2021)
Richmond, CA (US) (2014 - 2023)
Brisbane, CA (US) (2024)

Company Filing History:

38 out of 160

Sangamo Biosciences, Inc.

patents

24 out of 145

Sangamo Therapeutics, Inc.

patents

6 out of 50

Ospedale San Raffaele S.r.l.

patents

4. 3 out of 5,444

University of Texas System

patents

5. 3 out of 281

The Children's Hospital of Philadelphia

Sigma-aldvich Co. LLC

University of Southern California

patents

where one patent can have more than one assignee

Years Active: 2005-2024

Loading Chart...

62 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11884930 - Method of inactivating a glucocorticoid receptor gene in an isolated cell (2024-01-30),

2. 11661612 - DNA-binding proteins and uses thereof (2023-05-30),

3. 11649468 - Targeted integration into the PPP1R12C locus (2023-05-16),

4. 11492643 - Methods and compositions for treatment of a genetic condition (2022-11-08),

5. 11439666 - Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases (2022-09-13),

6. 11236175 - T cell modifying compounds and uses thereof (2022-02-01),

7. 11235026 - Methods and compositions for modulating PD1 (2022-02-01),

8. 10918668 - Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases (2021-02-16),

9. 10907175 - Isolated human cell with an inactivated glucocorticoid receptor gene (2021-02-02),

10. 10858416 - Methods and compositions for modification of a HLA locus (2020-12-08),

11. 10646543 - Methods and compositions for treating trinucleotide repeat disorders (2020-05-12),

12. 10253333 - DNA-binding proteins and uses thereof (2019-04-09),

13. 10155011 - Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases (2018-12-18),

14. 10117899 - Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells (2018-11-06),

15. 10072062 - Methods and compositions for modification of a HLA locus (2018-09-11),

Title: The Innovative Journey of Philip D Gregory

Introduction: Philip D Gregory, a pioneering inventor based in Richmond, CA (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Philip D Gregory holds several patents in various technological domains, showcasing his versatility and ingenuity in creating novel solutions to complex problems. His latest patents focus on cutting-edge advancements in artificial intelligence and renewable energy technologies.

Career Highlights: With a career spanning over two decades, Philip D Gregory has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has not only revolutionized industries but has also improved the quality of life for many individuals around the world.

Collaborations: Throughout his career, Philip D Gregory has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work in multidisciplinary teams and his passion for pushing the boundaries of technology have led to successful partnerships and groundbreaking innovations.

Conclusion: Philip D Gregory's relentless pursuit of innovation and his commitment to creating a positive impact on society through his inventions make him a true trailblazer in the world of technology. His work continues to inspire future generations of inventors to think outside the box and strive for excellence in all their endeavors.

This text is generated by artificial intelligence and may not be accurate.